Status:
TERMINATED
Hyperbaric Oxygen for COVID-19 Patients
Lead Sponsor:
NYU Langone Health
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyperbaric oxygen therapy (HBOT) treatment will be provided to patients as an adjunct to standard therapy for a cohort of 40 COVID19-positive patients with respiratory distress at NYU Winthrop Hospita...
Detailed Description
This is a single center prospective pilot cohort study to evaluate the safety and efficacy of hyperbaric oxygen therapy (HBOT) as an emergency investigational device for treating patients with a novel...
Eligibility Criteria
Inclusion
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Male or female, age \> 18 years
- Positive COVID 19 test
- Respiratory compromise defined by SpO2 \<93%
- Ability to sign informed consent
Exclusion
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Pregnancy
- Untreated Pneumothorax
Key Trial Info
Start Date :
April 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 29 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04332081
Start Date
April 6 2020
End Date
May 29 2020
Last Update
June 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Winthrop Hospital
Mineola, New York, United States, 11501